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Consensus holds that hematopoietic stem cells
(HSCs) give rise to multipotent progenitors (MPPs)
of reduced self-renewal potential and that MPPs
eventually produce lineage-committed progenitor
cells in a stepwise manner. Using a single-cell trans-
plantation system and marker mice, we unexpect-
edly found myeloid-restricted progenitors with
long-term repopulating activity (MyRPs), which are
lineage-committed to megakaryocytes, megakaryo-
cyte-erythroid cells, or common myeloid cells
(MkRPs, MERPs, or CMRPs, respectively) in the
phenotypically defined HSC compartment together
with HSCs. Paired daughter cell assays combined
with transplantation revealed that HSCs can give
rise to HSCs via symmetric division or directly dif-
ferentiate into MyRPs via asymmetric division
(yielding HSC-MkRP or HSC-CMRP pairs). These
myeloid bypass pathways could be essential for
fast responses to ablation stress. Our results show
that loss of self-renewal and stepwise progression
through specific differentiation stages are not essen-
tial for lineage commitment of HSCs and suggest a
revised model of hematopoietic differentiation.
INTRODUCTION
The hematopoietic system is maintained all through life by
hematopoietic stem cells (HSCs). Hierarchical relationships exist
amongHSCs, theirprogeny, andmaturebloodcells. Identification
of functionally discrete populations in the hematopoietic system1112 Cell 154, 1112–1126, August 29, 2013 ª2013 Elsevier Inc.underlies hierarchical differentiation models (Akashi et al., 2000;
Kondo et al., 1997; Nakorn et al., 2003). In thesemodels, multipo-
tent self-renewing HSCs, mainly characterized by a CD150+
CD34/lowFlt3c-Kit+Sca-1+lineage (CD150+CD34Flt3KSL)
phenotype (Christensen and Weissman, 2001; Kiel et al., 2005;
Morita et al., 2010; Morrison and Weissman, 1994; Osawa et al.,
1996), initially give rise to multipotent progenitors (MPPs) pheno-
typically defined as Flt3CD34+KSL cells. MPPs produce
Flt3+CD34+KSL lymphoid-primed multipotent progenitors
(LMPPs) (Adolfsson et al., 2005). MPPs and LMPPs are consid-
ered to be multipotent progenitor cells with limited or no self-
renewal activity, that is, allowing only short-term (up to 8 weeks)
multilineage repopulation. These multipotent progenitors
generate lineage-committed progenitors such as common
myeloid progenitors (CMPs) (Akashi et al., 2000), common
lymphoid progenitors (CLPs) (Kondo et al., 1997), or megakaryo-
cyte-erythroid progenitors (MEPs), with loss of self-renewal activ-
ity. Current models accept that HSC self-renewal capability is
associated with multipotency and that HSCs lose differentiation
potential in a stepwisemanner in theprocess of bloodmaturation.
According to the present ‘‘classical’’ model, hierarchical differ-
entiation proceeds with the first lineage commitment at the MPP
stage, giving rise to all mature blood lineages. This model of
a multipotent stem cell giving rise to a multipotent progenitor
cell has been derived from the hematopoietic system and is
commonly proposed as a blueprint for the hierarchy of other
stem cell compartments. Despite wide acceptance of this
concept, however, evidence from which hierarchical relation-
ships are inferred is somewhat scanty and not definitive. Several
recent studies have questioned this scheme of lineage commit-
ment largely because LMPPs with both neutrophil-monocyte
and lymphoid potentials, but little or nomegakaryocyte-erythroid
potential (MkE), have been detected (Adolfsson et al., 2005; Lai
and Kondo, 2006; Yoshida et al., 2006), suggesting that an
alternative MkE differentiation pathway may exist. However, the
issue of a branching point of MkE lineage remains controversial
(Forsberg et al., 2006; Lai et al., 2005; Nutt et al., 2005).
To analyze differentiation potentials of HSCs, simultaneous
analysis of the differentiation capacity of individual cells is essen-
tial (Akashi et al., 2000; Benz et al., 2012; Dykstra et al.,
2007; Kondo et al., 1997;Morita et al., 2010). Conventional in vivo
assays use the Ly5-congenic system to distinguish donor cells
from recipient or competitor cells. Because the Ly5 antigen is
expressed only on leukocytes, however, clonal and simulta-
neous analyses of lineage commitment of HSCs to five lineages,
including erythrocytes and platelets, have not been reported:
erythrocytes and platelets have always been excluded fromeval-
uation for multilineage reconstitution. A transplantation system
that can detect five mature blood lineages is required for accu-
rate examination of differentiation potentials of HSCs and
progenitor cells. Recently, we showed that CD150highCD34KSL
cells are enriched for myeloid-biased HSCs, which exhibit great
self-renewal activity and predominant myeloid reconstitution
(Morita et al., 2010), and that this most primitive HSC com-
partment contains myeloid-restricted repopulating cells. These
results suggested that a first lineage commitment toward
myeloid lineage takes place at the level of HSCs.
To test this hypothesis, we first developed a transgenic mouse
line in which not only T and B cells and neutrophils/monocytes
but also erythrocytes and platelets are labeled by Kusabira-
Orange (KuO) fluorescent protein, enabling in vivo tracing of
five lineages. Using single-cell transplantation of KuO-mouse
bone marrow (BM) cells, we found, in the phenotypically
defined HSC compartment, long-term repopulating cells with
differentiation potential restricted to myeloid, megakaryocyte-
erythroid, or megakaryocyte lineages at a single-cell level
(common myeloid repopulating progenitors [CMRPs],
megakaryocyte-erythroid repopulating progenitors [MERPs],
and megakaryocyte repopulating progenitors [MkRPs]),
providing evidence for dissociation of self-renewal capacity
from multipotency.
To examine whether HSCs directly differentiate into these
myeloid-restricted repopulating progenitors (MyRPs), we em-
ployed a paired daughter cell (PDC) assay combined with sin-
gle-cell transplantation. We were able to identify daughter cell
pairs in which one was an HSC and the other was an MkRP as
well as daughter cell pairs in which one was an HSC and the
other was a CMRP, demonstrating that direct lineage commit-
ment took place in an asymmetric manner at the HSC level
and that HSCs can directly differentiate into lineage-restricted
progenitors without passing through an MPP stage.
RESULTS
MyRPsAreContained in thePhenotypically DefinedHSC
Compartment
To analyze all kinds of progeny clonally and simultaneously, we
generated a transgenic mouse line in which Kusabira-Orange,
encoding red fluorescent protein, is stably expressed in all blood
cell lineages, including erythrocytes and platelets (KuO mice;
Hamanaka et al., 2013). This permitted five-lineage clonal tracing
of donor-derived blood cells generated after single-cell trans-plantation, including neutrophils/monocytes (nm), erythrocytes
(E), platelets (Plt), B cells (B), and T cells (T).
CD150+ cells in the CD34KSL fraction have long-term and
myeloid-biased repopulating activity (Kiel et al., 2005; Morita
et al., 2010). Furthermore, because preliminary work showed
that CD41+ cells in the CD150+CD34KSL fraction mainly recon-
stituted myeloid cells with somewhat decreased repopulating
activity (data not shown), we fractionated the CD34KSL popu-
lation into three cohorts comprising CD150+CD41 (fraction I),
CD150+CD41+ (fraction II), and CD150CD41 cells (fraction
III) (Figure 1A).We transplanted single cells from these three frac-
tions into a total of 287 lethally irradiated C57BL/6-Ly5.2 (Ly5.2)
mice, together with 2 3 105 competitor cells from C57BL/6-
Ly5.1/Ly5.2-F1 (Ly5.1/Ly5.2-F1) mice, in four independent
experiments (Figure 1B). Chimerism for donor-derived KuO+
cells in nm, E, Plt, B, and T lineages in the peripheral blood
(PB) of both primary and secondary recipient mice, as a percent-
age, was determined periodically (Figure S1 available online).
Our assay required new definitions, criteria, and terms. Recip-
ient mice were regarded as reconstituted when at least one type
of mature blood lineage contained donor-derived KuO+ cells
(0.1% or more) in PB at any time after transplantation. Of the
287 recipient mice, 28 died during follow-up after primary or sec-
ondary transplantations, and were eliminated from analyses. Of
259 mice, 130 (50.2%) were reconstituted with single fraction I,
fraction II, or fraction III cells. Among the repopulating cells, we
found three different types of multilineage repopulating cells.
The multilineage repopulating cells were operationally classed
as long-term HSCs (LT-HSCs), intermediate-term HSCs (IT-
HSCs), and short-term HSCs (ST-HSCs) according to the dura-
tion and level of multilineage reconstitution (Figure 1C). When
all five types ofmature blood cells in an individual mouse showed
stable chimerism (0.1% or more) 20 weeks after secondary
transplantation, the original single cell transplanted into the orig-
inal recipient mouse (which was also, subsequently, a donor
mouse for secondary transplantation) was retrospectively
defined as an LT-HSC (Figures 1C, 2A, and S2A). When five
types of mature blood cells in an individual mouse showed
chimerism (0.1%ormore) 24weeks after primary transplantation
but at least one lineage disappeared in secondary recipient
mice, the single cell transplanted into that individual mouse
was defined as an IT-HSC (Figures 1C, 2B, and S2B). IT-HSCs
in this study may correspond to HSCs described by Benveniste
et al. (Benveniste et al., 2010). When, in a primary recipient
mouse, mature blood cells of at least one lineage disappeared
(that is, showed less than 0.1%chimerism) before 24 weeks after
transplantation, the single cell transplanted into that mouse was
defined as an ST-HSC (Figures 1C, 2C, and S2C).
We were surprised to encounter in the phenotypically defined
HSC compartment (fractions I, II, and III) progenitor cells func-
tionally equivalent to CMPs, MEPs, and megakaryocyte progen-
itors (MkPs), but with repopulating activity at a single-cell level
(CMRPs, MERPs, and MkRPs, respectively; Figures 1C, 2D–2F,
and S2D–S2F). CMRPs show nm, E, and Plt reconstitution but
not lymphoid reconstitution (B and T lineages). MERPs show
only E and Plt reconstitution and MkRPs show only Plt reconsti-
tution.Ourdescription of these lineage-restrictedprogenitor cells
with repopulating activity was enabled by single-cellCell 154, 1112–1126, August 29, 2013 ª2013 Elsevier Inc. 1113
Figure 1. Experimental Design for In Vivo Analysis of Single Hematopoietic Stem and Progenitor Cells
(A) Gating strategy to purify single KuO+CD150+CD41CD34KSL (fraction I) cells, CD150+CD41+CD34KSL (fraction II) cells, CD150CD41CD34KSL
(fraction III) cells, Flt3CD34KSL cells (MPPs), and Flt3+CD34+KSL cells (LMPPs) from Kusabira-Orange (KuO) mouse BM cells. BM cells were stained with
antibodies and were gated as indicated. Doublets and dead cells were excluded before sorting. For single-cell sorting, the presence of one cell per well was
verified under an inverted microscope.
(B) Single fraction I, fraction II, or fraction III cells were sorted from BM cells of KuO mice and were individually transplanted with 2 3 105 competitor cells from
Ly5.1/Ly5.2-F1mice into lethally irradiated Ly5.2mice. Chimerism of KuO+ neutrophils/monocytes, erythrocytes, platelets, B cells, and T cells in peripheral blood
(legend continued on next page)
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transplantation analysis and by use of KuO mice, permitting
in vivo five-lineage tracing. Surprisingly, 26 of 37 CMRPs
(70.3%), 3 of 5 MERPs (60%), and 12 of 22 MkRP (54.5%) ex-
hibited long-term repopulating activity for more than 8 weeks in
primary recipients and, in fourmice, even in secondary recipients
(Figures 2D–F). Although differentiation capacity of the progeni-
tors was restricted, the cells’ self-renewal ability was significant,
indicating that multipotency and self-renewal ability were disso-
ciated. In addition, 50 MPPs or LMPPs did not reconstitute nm
and Plt more than 8 weeks after transplant (Figures 2G and 2H),
indicating that these CMRPs, MERPs, andMkRPs havemore re-
populating activity than do cells in the CD34+KSL fraction.
MkRPs and MERPs Are Detected Exclusively in
Fractions I and II but Not in Fraction III
Of the total 130 reconstituted mice, 46 of 83 mice (55.4%), 39 of
88 mice (44.3%), and 45 of 88 mice (51.1%) were reconstituted
with single fraction I, fraction II, and fraction III cells, respectively.
LT-HSCswere observed only in recipients of fraction I cells (13 of
83 mice; Figures 3A and 3B). ST-HSCs were detected in recipi-
ents of fraction II and fraction III cells (1 of 88 mice and 25 of 88
mice, respectively) but not in recipients of fraction I cells. In
contrast, IT-HSCs were detected in recipient mice of all three
populations (8 of 83 mice receiving single fraction I cells, 3 of
88 mice receiving single fraction II cells, and 7 of 88 mice
receiving single fraction III cells).
Among recipients that showed engraftment, CMRPs were
detected in 11 of 46 mice (23.9%), 19 of 39 mice (48.7%), and
7 of 45 mice (15.6%) transplanted with single fraction I, fraction
II, and fraction III cells, respectively. MERPs were detected in 3
of 46 mice (6.5%) and 2 of 39 mice (5.1%) transplanted with
single fraction I and fraction II cells, respectively, but not in
mice transplanted with single fraction III cells. MkRPs were
also observed in 11 of 46 mice (23.9%) and 11 of 39 mice
(28.2%) transplanted with fraction I and fraction II cells, respec-
tively, but not in mice transplanted with fraction III cells. Fraction
II contains more MyRPs than multipotent HSCs, whereas frac-
tion III contains more multipotent HSCs than MyRPs. Unlike
myeloid reconstitution, CLP-type reconstitution (by cells
showing only B and/or T cell differentiation potentials) was not
observed at all in the three fractions tested. In contrast, nmB-
type reconstitution was observed in fraction III cells (Figure S3).
These results showed that CD150 expression can be used to
discriminate MkRPs and MERPs among CD34KSL cells. In
addition, they show that CD41 is a useful marker when purifying
or excluding HSCs from CD150+CD34KSL cells. That the HSC(PB) was analyzed 2, 3, 4, 8, 16, and 24 weeks after primary transplantation (in ad
20 weeks, and some were also analyzed at 12 and 20 weeks). Secondary transp
recipient mice. PB chimerism was analyzed 4, 12, 16, and 20 weeks after secon
(C)Definitionof repopulatingcell:Whenall five typesofmaturebloodcells in an indiv
transplantation, the original single cell was retrospectively defined as a long-term
showed chimerism (0.1% or more) 24 weeks after primary transplantation but at le
wasdefinedas an intermediate-termHSC (IT-HSC).When, in a primary recipientm
than 0.1%chimerism) before 24weeks after transplantation, the original single cell
erythrocytes, and platelets, but not cells of B and T lineages, were detected in mi
genitor (CMRP). When only erythrocytes and platelets were detected in mice, th
progenitor (MERP). When only platelets were detected in mice, the original single
See also Figures S1 and S2.compartment contains MyRPs but not CLP-type progenitors
with repopulating ability at a single-cell level suggests that
myeloid differentiation is developmentally early, that is, more
closely related to HSCs in the development process, than is
lymphoid differentiation, an event further downstream.
Reconstitution of Plt was observed in 126 of 130 reconstituted
mice (96.9%; 4 mice without Plt). Of note is that the four mice
without KuO+ Plt reconstitution all had received single fraction III
cells (Figure 3B). In addition, Plt reconstitution was always
detected first among the five blood lineages in recipient mice,
including mice that had received single HSCs (Figures 2 and 3A,
anddatanot shown).Plt chimerismalso tendedtodecreasebefore
thatof cells in theother fourblood lineageswhenHSCself-renewal
finally ceased. These findings suggest a close relationship be-
tween HSCs and megakaryocyte lineages and that Plt reconstitu-
tion levels are good indicators of self-renewal potential.
CMRPs and MkRPs Generated Fractions I/II Cells and
MPP Fraction Cells but Not Fraction III Cells, LMPP
Fraction Cells, or CLPs
To determine the contribution of each repopulating progenitors
to BM cells, we analyzed BM cells of LT-HSC-, IT-HSC-,
ST-HSC-, CMRP-, and MkRP-recipient mice for KuO+ cells
among CD150+CD34KSL cells (fractions I/II, corresponding
to myeloid-biased/balanced HSCs, My-HSCs), CD150
CD34KSL cells (fraction III, corresponding to lymphoid-biased
HSCs, Ly-HSCs), Flt3CD34+KSL cells (corresponding to
MPPs), Flt3+CD34+KSL cells (corresponding to LMPPs), FcgR
CD34+K+SL cells (corresponding to CMPs), FcgRCD34
K+SL cells (corresponding to MEPs), FcgR+CD34+K+SL
cells (corresponding to GMPs), CD150+CD41+K+SL (cor-
responding to MkPs), and IL7Ra+Flt3+KmidSmidL cells (corre-
sponding to CLPs).
As expected, among KuO+ BM cells in three LT-HSCmice, we
detected all kinds of phenotypically defined HSCs (fractions I/II
and fraction III) and progenitor cells (MPPs and LMPPs; CMPs,
MEPs, GMPs, MkPs, and CLPs) (Table 1 and Figure S4A). In
four IT-HSC mice, KuO+ hematopoietic cell populations were
always detected except among fractions I/II cells and fraction
III cells (Table 1 and Figure S4B). Fractions I/II cells and fraction
III cells were detected in one of four and two of four mice tested,
respectively. On the other hand, in BM cells of ST-HSCmice (n =
4), we did not detect KuO+ cells from fractions I/II and fraction III
(Table 1 and Figure S4C). In one of four ST-HSC mice, MPP and
LMPP fraction cells were detected. Of importance is that in
CMRP mice (n = 3), KuO+ fraction III cells, LMPP fraction cells,dition, some mice were also analyzed at 12 weeks, some were also analyzed at
lantation was performed by transferring 1 3 107 whole BM cells from primary
dary transplantation.
idualmouseshowedstablechimerism (0.1%ormore) 20weeksafter secondary
HSC (LT-HSC). When five types of mature blood cells in an individual mouse
ast one lineage disappeared in secondary recipient mice, the original single cell
ouse,maturebloodcells of at least one lineagedisappeared (that is, showed less
was defined as a short-termHSC (ST-HSC).When only neutrophils/monocytes,
ce, the original single cell was defined as a common myeloid repopulating pro-
e original single cell was defined as a megakaryocyte-erythroid repopulating
cell was defined as a megakaryocyte repopulating progenitor (MkRP).
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Figure 2. Myeloid-Restricted Progenitors with Long-TermRepopulating Ability Are Present in the Phenotypically DefinedHSCCompartment
Single fraction I, fraction II, or fraction III cells, 50MPPs or 50 LMPPswith 23 105 competitor cells (Ly5.1/Ly5.2-F1) were transplanted into lethally irradiated Ly5.2
mice. PB chimerism was analyzed periodically in primary and secondary recipient mice. Based on reconstitution kinetics data, single test donor cells were
classed as LT-HSCs, IT-HSCs, ST-HSCs, CMRPs, MERPs, MkRPs, or ‘‘other.’’ Chimerism kinetics of each lineage (neutrophil/monocyte, erythrocyte, platelet, B
cell, and T cell) are shown for mice that had received a single LT-HSC (n = 13), IT-HSC (n = 18), ST-HSC (n = 26), CMRP (n = 37), MERP (n = 5), or MkRP (n = 22);
multiple MPPs (n = 5); or multiple LMPPs (n = 4). See also Figure S2.
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and CLPs, the fractions thought to tend to produce lymphoid
lineages inBMcells,were never detected. KuO+ fractions I/II cells
were detected in BM of CMRP mice (n = 2) transplanted with
single fraction I cells at 24 weeks after transplant (Figure S4D).
However, in a CMRP mouse with a tendency toward decreasing
chimerism, KuO+ fractions I/II cells were not detected (n = 1,
Table 1; and data not shown). Similarly, in MkRP mice we did
not detect KuO+ fraction III cells, LMPP fraction cells, GMPs, or
CLPs, whereas fractions I/II cells and MPP fraction cells were
detected in three of four mice (Table 1 and Figure S4E).
These results indicated that HSCs with longer-term repopu-
lating activity yield more primitive phenotypically defined
HSCs in BM cells, suggesting that LT-HSCs are located up-
stream of IT-HSCs and ST-HSCs. Furthermore, these results
strongly support the proposals that CMRPs and MkRPs have
self-renewal activity with myeloid-restricted potentials and that
they produce mature myeloid blood cells without passing
through fraction III, LMPP, and CLP stages, suggesting that
these BM cell fractions are not necessary for production of
PB myeloid cells (nm, E, and Plt).
CD34+KSL Fraction Contains Myeloid-Restricted
Progenitors with Lower Repopulating Capability than
MyRPs
Because CMRPs and MkRP gave rise to MPP fraction cells but
not LMPP fraction cells, we hypothesized that the MPP fraction
contains myeloid-restricted progenitor cells. To test this hypoth-
esis by assaying the repopulating activity of conventional MPP
and LMPP fraction cells, we transplanted ten or single MPP or
LMPP fraction cells into lethally irradiated Ly5.2 mice with 2 3
105 competitor cells from Ly5.1/Ly5.2-F1 mice. PB chimerism
was analyzed periodically, allowing determination in each recip-
ient mouse of the differentiation potentials of transplanted cells
along nm, E, Plt, B, or T lineages (Figure 4). Four of nine recipient
mice showed CMP-type reconstitution (mice 6–9) when ten
MPPs were transplanted into mice (Figure 4A). However, repo-
pulating activity was significantly diminished compared with
that of CMRPs, MERPs, and MkRPs in the CD34KSL fraction
(Figure 2 and Figure 4A). In contrast, when ten LMPPs were
transplanted into mice, we did not detect CMP-type reconstitu-
tion (Figure 4B). Interestingly, the ten LMPP fraction cells yield
a variety of cell types (nm, nmB, nmBT, nmEBT, nmEPltB, and
nmEPltBT) and tend to produce nm and B lineages but not Plt.
Full-lineage reconstitution was detected only in three of nine
and one of nine recipient mice transplanted with ten MPPs or
LMPPs, respectively (Figures 4A and 4B). Clonal analysis of
MPP and LMPP fraction cells also demonstrated the existence
of cells with differentiation potentials similar to those of CMPs,
MEPs, and MkPs in the MPP fraction and the existence of cells
with various differentiation potentials (nm, B, nmB, nmEB,
nmET, nmEPlt, and nmEPltB) in the LMPP fraction (Figure S5).
Unexpectedly, ‘‘real’’ MPP- and LMPP-type reconstitution was
not detected in 26 mice receiving single MPPs and in 48 mice
receiving single LMPPs, respectively. In addition, 100–250
myeloid progenitor cells (K+SL or CD150+CD41+K+SL) did
not reconstitute nmor Plt lineagesmore than 3weeks after trans-
plant (data not shown), indicating that repopulating activity of
conventional myeloid progenitors (CMPs, MEPs, GMPs, andMkPs) is much weaker than that of cells in the MPP and LMPP
fractions.
These results indicate that CMRPs, MERPs, and MkRPs in the
CD34KSL fraction (fractions I, II, and III) are not progeny of cells
in the CD34+KSL fraction (MPPs and LMPPs) and that the MPP
fraction containsmyeloid-restricted progenitors, suggesting that
these progenitors are downstream of CMRPs, MERPs, and/or
MkRPs in fractions I/II and fraction III. Furthermore, these results
indicate that the MPP and LMPP fractions contain lineage-
committed progenitors with diverse differentiation potentials
and fewer ‘‘real’’ MPPs and/or LMPPs.
MkRPs Are Directly Derived from LT-HSCs
Results of serial transplantation strongly suggest that CMRPs,
MERPs, and/or MkRPs are directly derived from HSCs. First, to
determine whether megakaryocyte-restricted colonies exist un-
der in vitro culture conditions, we cultured single CD150+CD34
KSL cells (fractions I/II) and CD150CD34 KSL cells (fraction III)
in serum-free medium with SCF and TPO or in serum-containing
medium with SCF, TPO, IL-3, IL-6, and EPO. We have observed
that colonies exclusively composed of CD41+ megakaryocyte
progenitors are formed shortly after cells in fractions I/II, but
not in fraction III, are placed in culture (Figures S6A–S6E). The re-
sults again indicated that these megakaryocyte progenitors are
contained in fractions I/II but not in fraction III, suggesting that
these progenitors are immediate progeny of HSCs.
To elucidate whether CMRPs, MERPs, and/or MkRPs directly
arise fromHSCs in vivo, we next performed PDC assays followed
by single-cell transplants. PDC assays enable comparison of
differentiation potentials of two daughter cells after one division
of the mother cell (Suda et al., 1984; Takano et al., 2004). This
experimental system, with in vitro/in vivo clonal analysis, enables
direct assessment of lineage commitment at the level of HSCs.
Fraction I cells purified from KuO mouse BM cells were individu-
ally sorted into 96-well plates and cultured in the presence of
SCF and TPO for 36–40 hr. As soon as they divided once, the
resultant two daughter cells were separated by micromanipula-
tion (Figure 5A). Individual daughter cells were transplanted into
lethally irradiated Ly5.2 mice with 2 3 105 competitor cells from
Ly5.1/Ly5.2-F1 mouse BM cells.
Two hundred and four daughter cells in total (102 pairs) were
successfully micromanipulated and transplanted into lethally
irradiated Ly5.2 recipient mice. In 31 of 102 pairs, neither
daughter cell reconstituted hematopoiesis in its recipient mouse.
In 27 of 102 pairs, both daughter cells reconstituted hemato-
poiesis in their recipient mice. Among the 27 daughter cell pairs,
we detected distinct patterns: One LT-HSC-LT-HSC pair
(3.7%), 3 LT-HSC-IT/ST-HSC pairs (11.1%), 9 IT/ST-HSC-IT/
ST-HSC pairs (33.3%), 2 LT-HSC-MkRP pairs (7.4%), 3 ST-
HSC-MkRP pairs (11.1%), 2 ST-HSC-CMRP pairs (7.4%), 3
CMRP-MkRP pairs (11.1%), 2 CMRP-CMRP pairs (7.4%), and
2 MkRP-MkRP pairs (7.4%; Figures 5B, 5C, and 5D, and Table
S1). Among 13 pairs yielded by symmetric division of HSCs,
we detected 7 ST-HSC-ST-HSC pairs but only 1 LT-HSC-LT-
HSC pair, despite the fact that self-renewal capability is stron-
gest in fraction I. The daughter cells yielded solid, persistent
five-lineage engraftment even in secondary recipients (Figure 5B,
left). We have reported such symmetrical self-renewal division inCell 154, 1112–1126, August 29, 2013 ª2013 Elsevier Inc. 1117
(legend on next page)
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Table 1. BM Populations Reconstituted by Single LT-HSCs, IT-HSCs, ST-HSCs, CMRPs, and MkRPs
Test Cells
Presence in BM of Phenotypically Defined Populations Derived from Single KuO+ Donor Cells
My-HSC Ly-HSC
MPP LMPP CMP MEP GMP MkP CLPFractions I/II Fraction III
LT-HSC 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3
IT-HSC 1/4 2/4 4/4 4/4 4/4 4/4 4/4 4/4 4/4
ST-HSC 0/4 0/4 1/4 1/4 2/4 2/4 2/4 2/4 3/4
CMRP 2/3 0/3 3/3 0/3 3/3 3/3 1/3 3/3 0/3
MkRP 3/4 0/4 3/4 0/4 2/4 3/4 0/4 3/4 0/4
The presence in BM of phenotypically defined populations derived from single KuO+ donor cells was assessed. When secondary transplantation was
performed more than 16 weeks after primary transplantation, BM cells surplus to secondary transplantation were examined. Test donor cells were
retrospectively identified as LT-HSCs, IT-HSCs, ST-HSCs, CMRPs, or MkRPs. Phenotypically defined populations are; Myeloid-biased and balanced
HSCs (My-HSCs), CD150high or medCD34KSL cells; lymphoid-biased HSCs (Ly-HSCs), CD150CD34KSL cells; MPPs, Flt3CD34+KSL cells;
LMPPs, Flt3+CD34+KSL cells; CMPs, CD34+FcgreceptorKit+Sca-1Lincells; MEPs, CD34FcgreceptorKit+Sca-1Lincells; GMPs, CD34+
Fcgreceptor+Kit+Sca-1Lincells; MkPs, CD150+CD41+Kit+Sca-1Lincells; and CLPs, IL-7 receptora+Flt3+KitmedSca-1medLincells. Numbers of
mice with KuO+ cells in the indicated population/numbers of mice examined are shown. See also Figure S4.Lnk/ HSCs in primary recipient mice (Seita et al., 2007) but, to
our knowledge, this is the first definitive evidence for symmetri-
cal self-renewal division of wild-type HSCs even in secondary
recipient mice. Although these HSCs apparently are rare even
among cells in the highly enriched HSC compartment, they
may well be a good target for in vitro expansion.
To determine effects of short-term (36–40 hr) culture in this
PDC assay on lymphoid and myeloid differentiation potentials,
we compared reconstitution capabilities between freshly iso-
lated fraction I cells and such cells after one division in vitro.
No difference was appreciated in proportions of multipotent
HSCs (including LT-, IT- and ST-HSCs), CMRPs, MERPs, and
MkRPs between freshly isolated fraction I cells (representing
mother cells) and fraction I cells allowed to divide once in
short-term culture (representing daughter cells) (p > 0.1, Fig-
ure S6F). Despite the fact that LT-HSCs have the highest repopu-
lating capacity in vivo (Figure 2), numbers of ST-HSCs but not of
LT-HSCs were significantly increased in the PDC assay (p <
0.05). This is likely due to a limitation of the in vitro culture system
employed. With even short-term culture in the PDC assay, a sig-
nificant proportion of LT-HSCs turned into IT- and/or ST-HSCs
(Figure S6F). Next, we compared differentiation potentials along
each lineage (nm, E, Plt, B, and T) between the freshly isolated
fraction I cells and singly divided fraction I cells (Figure S6G). Dif-Figure 3. MERPs and MkRPs Are Present among Fraction I and II but
Single fraction I, fraction II, or fraction III cells were transplanted with 23 105 comp
were detected in 46 of 83 mice transplanted with single fraction I cells (55.4%), 39
transplanted with single fraction III cells (51.1%). Based on reconstitution kinetic
CMRPs, MERPs, MkRPs, or ‘‘other.’’
(A) Average reconstitution kinetics of LT-HSCs, IT-HSCs, ST-HSCs, CMRPs, MER
neutrophil/monocyte, nm; erythrocyte, E; B cell, B; and T cell, T). Error bar, SEM
(B) All repopulating cells among fraction I, fraction II, and fraction III are classed
fraction I cells exhibited reconstitutive behavior of LT-HSCs (n = 13, 15.7%), IT-HS
11, 13.3%). Single fraction II cells showed reconstitutive behavior of IT-HSCs (n =
MkRPs (n = 11, 12.5%), or ‘‘other’’ (n = 3, 3.4%). ‘‘Other’’-type reconstitution encom
and T)-type (n = 2, 2.3%) reconstitution. Single fraction III cells exhibited reconstitu
8.0%), and others (n = 6, 6.8%). ‘‘Other’’-type reconstitution encompassed nmBT
nmEPltB (nm, E, Plt and B)-type (n = 2, 2.3%) reconstitution.
See also Figure S3.ferentiation potentials were not significantly influenced by short-
term in vitro culture, indicating that the PDC assay itself did not
alter differentiation. Thus, PDC assay combined with single-cell
transplants can be regarded as a rational experimental method
of assessing differentiation potentials of daughter cells in vivo.
The existence of LT-HSC-MkRP pairs, along with the pro-
longed repopulating activity of MkRPs compared with MPPs
and LMPPs (Figure 5C), indicates that LT-HSCs can directly
differentiate into long-term repopulation-competent MkRPs
without passing through the intermediate stages of conventional
functionally defined MPPs. This is an important demonstration
that megakaryocyte lineage commitment can also occur at the
HSC level through a distinct pathway (Figure 6). Of further inter-
est is that we did not detect LT-HSC-CMRP pairs; instead, we
found ST-HSC-CMRP pairs (Figure 5D), indicating that myeloid
lineage commitment can occur at this level and does not need
to go through the CMP-CLP separation stage. MkRPs were
also produced from CMRPs via one division without passing
through MEP status.
Discussion
Here we report myeloid-restricted progenitors with long-term
repopulating activity and direct differentiation pathways from
HSCs to these myeloid-restricted progenitors using five lineageNot among Fraction III
etitor cells (Ly5.1/Ly5.2-F1) into lethally irradiated Ly5.2mice. KuO+ blood cells
of 88 mice transplanted with single fraction II cells (44.3%), and 45 of 88 mice
s data, single test donor cells were classed as LT-HSCs, IT-HSCs, ST-HSCs,
Ps, and MkRPs in fraction I, fraction II, and fraction III are shown (platelet, Plt;
; for numbers of mice, see (B).
as LT-HSCs, IT-HSCs, ST-HSCs, CMRPs, MERPs, MkRPs, or ‘‘other.’’ Single
Cs (n = 8, 9.6%), CMRPs (n = 11, 13.3%), MERPs (n = 3, 3.6%), or MkRPs (n =
3, 3.4%), ST-HSCs (n = 1, 1.1%), CMRPs (n = 19, 21.6%), MERPs (n = 2, 2.3%),
passed nmEPltB (nm, E, Plt, and B)-type (n = 1, 1.1%) and nmEPltT (nm, E, Plt,
tive behavior of IT-HSCs (n = 7, 8.0%), ST-HSCs (n = 25, 28.4%), CMRPs (n = 7,
E (nm, E, B, and T)-type (n = 2, 2.3%), nmB (nm and B)-type (n = 2, 2.3%), and
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Figure 4. CD34+KSL Fraction Contains Myeloid-Restricted Progenitors with Lower Repopulating Capability than MyRPs
Ten Flt3CD34+KSL cells (MPPs; A), or ten Flt3+CD34+KSL cells (LMPPs; B) were transplanted with 2 3 105 competitor cells (Ly5.1/Ly5.2-F1) into each of 18
lethally irradiated Ly5.2 mice (two cohorts of nine mice each). Differentiation potentials of transplanted cells into mature blood lineages (platelet, neutrophil/
monocyte, erythrocyte, B cell, and T cell) in each mouse are shown with colored boxes (yellow, black, red, blue, and green, respectively). Reconstitution kinetics
data of all mice transplanted with MPPs (A) or LMPPs (B) are shown at right.
See also Figure S5.tracing system. We studied reconstitution kinetics at 1- to 4-
week intervals for up to 20–24 weeks in primary and secondary
transplant recipients after transplantation of single KuO mouse
hematopoietic stem/progenitor cells. To the best of our knowl-
edge, this is the most vigorous and thorough experimental sys-
tem in which to characterize hematopoietic stem/progenitor
activities at the clonal level. Using this system, after examining1120 Cell 154, 1112–1126, August 29, 2013 ª2013 Elsevier Inc.287 single HSC transplants, we were able to classify HSCs into
three clearly defined groups (LT-HSCs, IT-HSCs, and ST-
HSCs) according to reconstitution kinetics in primary and sec-
ondary transplant recipients. Both LT- and IT-HSCs fulfill current
criteria for HSC status, viz., T, B and nm lineage reconstitution
4 months after transplantation, but LT-HSCs are more powerful,
with multilineage reconstitution potential unchanged in both
primary and secondary recipients. IT- and ST-HSCs, by
contrast, lose their reconstitution activity in secondary or primary
recipients. LT-HSCs are distinct in that donor chimerism never
declines during a 20–24-week observation period in either pri-
mary or secondary recipients. Although at present LT-HSCs
can be identified only in retrospect, they do represent ‘‘true’’
HSCs. Based on their reconstitution kinetics, LT-HSCs can be
detected by measuring donor chimerism at 12 and 24 weeks
after transplantation in the primary recipient and at 4 and
20 weeks after transplantation in the secondary recipient. These
classifications, under our assay conditions in combination with
PDCassays, permitted demonstration of symmetric self-renewal
division of HSCs as an actual event, albeit a very rare one. Pro-
spective isolation and molecular characterization of these three
classes of HSCsmay provide an opportunity to search for mech-
anisms of HSC self-renewal and expansion.
We foundthatPltwas thefirst element toappear after transplan-
tation of CD34KSL cells; indeed, in >96% of recipients that
showed engraftment, early Plt reconstitution was observed. Inter-
estingly, that thrombocytogenesis recovers earliest among these
five forms of hematopoiesis is recognized in human BM and PB
stem cell transplantation (Vellenga et al., 2001). On the other
hand, Plt tended to decrease first among the five mature blood
lineages as HSC activity deteriorated. The tight association be-
tween Plt lineage reconstitution and HSC activity after transplan-
tation led us to think that a pathway may exist that preferentially
producesmyeloidcells, especiallyPlt. In this regard,Plt chimerism
is an important parameter for detection of HSC activity. Myeloid
cells (erythroid- and macrophage-like cells) reportedly emerge
earlier in evolution (Hansen and Zapata, 1998) and also ontogeni-
cally develop earlier than lymphoid cells (Cumano and Godin,
2001). These observations may be related to our findings.
In contrast to previous studies, we found lineage-restricted
progenitor cells with long-term repopulating ability and differ-
entiation potential restricted to megakaryocyte, megakaryo-
cyte-erhtroid, or common myeloid lineages. Some of them
manifested this lineage-restricted repopulating ability even in
secondary recipients, excluding the possibility that lineage re-
strictions in repopulation resulted from niche factors. For
example, even if niche factors are postulated that can direct
commitment of a HSC only toward the megakaryocyte lineage,
this HSC (or all HSCs generated from this HSC) must home to
the same niche, one that directs the multipotent cell to generate
progeny only along the megakaryocyte lineage, in secondary
recipient BM. Otherwise, we should see generation of various
lineage cells in secondary recipient mice. In addition, whereas
multipotent HSCs were found in all three HSC subpopulations
(fractions I–III), we detected MkRPs and MERPs only in fractions
I and II but not in fraction III. Unless this putativeMk- orME-direct-
ing niche affects only HSCs in fractions I and II, we should see
generation of MkRPs and MERPs from all three fractions. Our
data as an ensemble indicate that lineage-restricted repopulation
is not a result of niche factors that direct differentiation of HSCs
only toward certain lineage(s) and that lineage-restricted progen-
itor cells exist in the most primitive HSC compartment. Although
the possibility that that lineage commitment resulted from niche
factors cannot be totally excluded, we think that MkRP and
MERPdifferentiationare regulated largely bycell-intrinsic factors.Our PDC assay combined with single-cell transplantation
allows us to assess differentiation potentials of daughter cells.
Although TPO is known to have an instructive role in megakaryo-
cytes, we have previously reported that megakaryocyte colony
formation is not influenced by culturing CD34KSL cells with
cytokine combinations in PDC assay such as SCF alone,
SCF + IL-3, SCF + TPO, and SCF + IL-3 + TPO (Takano et al.,
2004). In fact, although both fraction I and III cells express TPO
receptor, MkRPs were detected only in daughter cells of fraction
I but not in fraction III (Table S1 and data not shown). We think
that TPO does not have an instructive role on HSCs for commit-
ment of cells in the HSC compartment toward megakaryocyte
lineage. In PDC analyses, asymmetric self-renewal divisions
producing HSC-MkRP, HSC-CMRP, or CMRP-MkRP combina-
tions were found, clearly demonstrating a direct commitment of
fraction I HSCs to lineage-restricted progenitors. Unexpectedly,
we did not detect HSC-MERP pairs in this series of experiments,
which probably is consonant with the low frequency of MERPs in
fraction I (Figure 3). CMRPs were found more frequently than
MERPs, yet we did not see an LT-HSC-CMRP pair upon PDC
analysis. As shown in Figure S6F, short-term culture significantly
decreases the frequency with which LT-HSCs are seen.We think
that this is the principal reason why our PDC assay did not
demonstrate LT-HSC-CMRP pairs. Alternatively, given that
CMRPs are present not only in fractions I /II but also in fraction
III in contrast to the exclusive distribution of MkRPs and MERPs
in fractions I/II, CMRPs may be mainly generated from IT-HSCs
and/or ST-HSCs but not from LT-HSCs.
With respect to symmetric self-renewal divisions, we found
HSC-HSC, CMRP-CMRP, and MkRP-MkRP combinations,
which confirms these cell types’ repopulating ability. Of further
importance is that we did not detect any HSC-CLP or CMP-
CLP daughter cell pairs in our assays. These data support the
argument that HSCs preferentially produce particular myeloid
progenitors, such as MkRPs and CMRPs, but not lymphoid
progenitors. Highly purified HSCs are transcriptionally primed
primarily along megakaryocyte-erythrocyte and neutrophil/
monocyte lines, but not lymphoid lines; lymphoid priming was
instead observed in MPPs and LMPPs (Akashi et al., 2003; Ma˚n-
sson et al., 2007; Ye et al., 2003). Similarities in gene-expression
pattern have been reported between HSCs and megakaryocyte-
lineage cells (Huang and Cantor, 2009; Kent et al., 2009; Miya-
moto et al., 2002). These are compatible with our findings that
MkRPs, MERPs, and CMRPs are close to HSCs in develop-
mental pathways and that MkRPs and CMRPs are directly
derived from HSCs. These data show that most primitive HSCs
directly commit to lineage-restricted cells upstream of the MPP
stage. In a series of single-cell experiments using freshly isolated
fraction III cells, we found recipients reconstituted with nmB cells
(Figure S3), but we never identified recipients reconstituted with
nmBT and BT cells. In addition, single LMPPs reconstituted the
nm lineage in 15 of 16 mice (Figure S5). These data are compat-
ible with the model proposed by Kawamoto et al. (2010).
Of importance is that these MyRPs are not minor populations
of cells. After single-cell transplantation of cells in the highly
enriched HSC compartment (fraction I), among the 46 recipients
that showed engraftment, 21 (45%) were engrafted by HSCs
(multilineage reconstitution), 11 (24%) by MkRP cells, 11 (24%)Cell 154, 1112–1126, August 29, 2013 ª2013 Elsevier Inc. 1121
(legend on next page)
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Figure 6. Myeloid Bypass Model in Hematopoietic Stem Cells
HSCs self-renew and give rise to lineage-restricted progenitor cells. In the conventional hematopoietic differentiation model (right side), HSCs in the CD34KSL
population differentiate into multipotent progenitors (MPPs, Flt3CD34+KSL) of reduced self-renewal potential and MPPs eventually produce lymphoid-primed
multipotent progenitors (LMPPs, Flt3+CD34+KSL) or lineage-committed progenitor cells in a stepwise manner. All mature blood lineages are considered to pass
through the MPP and/or LMPP stage in the CD34+KSL population. Subsets of HSCs (myeloid-biased, balanced, and lymphoid-biased HSCs; and a, b, g, and
d cells) are reported by other groups (Mu¨ller-Sieburg et al., 2002; Dykstra et al., 2007). In contrast, in the myeloid bypass model (left side), the CD34KSL cell
population contains CMRPs, MERPs, and MkRPs in addition to HSCs. These MyRPs are produced by HSCs (LT-HSCs, IT-HSCs or ST-HSCs). MyRPs can
clonally expand via self-renewal as in HSCs, B cells, and T cells. The CD34+KSL population, which is downstream from the CD34KSL population, also contains
lineage-committed progenitors including myeloid-restricted progenitors, whereas ‘‘true’’ MPPs and LMPPs are minor populations in the CD34+KSL population.
Together, MyRPs, rather than ‘‘MPPs and LMPPs,’’ are considered to be themajor suppliers of myeloid cells (platelets, erythrocytes, and neutrophils/monocytes)
in the hematopoietic system at a single-cell level. LMPP fraction yields cells with various differentiation potentials (B, nm, nmB, nmET, nmEB, nmEPlt, and
nmEPltB) and these progenitors might derive from ST-HSCs in the CD34KSL population but not from MPPs in the CD34+KSL population. Because cells in the
CD34+KSL fraction have oligopotent differentiation potentials rather than multipotent potentials, CD34+KSL cells are considered to be OPPs.byCMRP cells, and 3 (7%) byMERP cells. These newly identified
repopulating progenitors thus represent nearly half the cells in
the more primitive HSC compartment. In addition, they possess
repopulating activity over 8 weeks at a single-cell level, whereas
cells in the CD34+KSL fraction that contained MPPs and LMPPs
can reconstitute myeloid cells for no more than 8 weeks even
after transplantation of 50 cells. Of great importance is that the
‘‘MPP and LMPP’’ fractions contain fewer multipotent cellsFigure 5. HSCs Asymmetrically Give Rise to HSCs and to MkRPs or C
(A) Single fraction I cells from KuO mice were sorted into 96-well plates, one cell
during which interval the individual cells had divided once, the two daughter cells
into 204 individual (102 paired) lethally irradiated Ly5.2 mice with 2 3 105 compe
periodically analyzed after transplantation. The platelet, neutrophil/monocyte, e
determined. The mother cells were considered to have had the combined differen
cells reconstituted hematopoiesis in recipient mice.
(B–D) Representative reconstitution kinetics for HSC-HSC (B), HSC-MkRP (C), and
repopulating cell type in daughter cells are shown in Table S1.
See also Figure S6.than expected even when ten cells were transplanted (Figure 4).
In fact, single MPPs or LMPPs did not show ‘‘real’’ MPP- or
LMPP-type reconstitution in 26 mice receiving single MPPs or
in 48 mice receiving single LMPPs. These data indicate that cells
in MPP and LMPP fraction are oligopotent progenitors (OPPs)
rather than multipotent progenitors and suggest that MyRPs,
rather than conventional ‘‘MPPs and LMPPs,’’ are themajor sup-
pliers of myeloid cells in the hematopoietic system (Figure 6).MRPs
per well, and were incubated in the presence of SCF and TPO. After 36–40 hr,
resulting from division of each initially sorted cell were individually transplanted
titor cells from a Ly5.1/Ly5.2-F1 mouse. PB cells from the recipient mice were
rythrocyte, B cell, and T cell differentiation potentials in daughter cells were
tiation potentials of the two daughter cells. In 27 out of 102 pairs, both daughter
HSC-CMRP, CMRP-CMRP, andCMRP-MkRPpairs (D) are shown. All data for
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Forsberg and her colleagues, in a recent study using a lineage-
tracing mouse model that elegantly enables direct assessment
of differentiation pathways in vivo, concluded that hematopoietic
lineage separation occurs downstream of Flt3 upregulation in
LMPP fraction (Boyer et al., 2011). Although this appears incon-
sistent with our results, Flt3 is likely expressed in cells at any
point along the myeloid bypass differentiation pathways, and
their lineage tracing system also detects cells developed through
these pathways. Their conclusion holds; however, Flt3 expres-
sion is not exclusive to phenotypically defined LMPPs. Gilliland’s
group also suggested an alternative megakaryocyte differentia-
tion pathway in KSL cells, based on analysis of gene-knockout
mice (Cornejo et al., 2011; Mercher et al., 2008). Their hypothesis
of megakaryocyte differentiation is in harmony with our myeloid
bypass model.
Our findings, viewed overall, permit us to propose a myeloid
bypass differentiation pathway directly branching from the
most primitive HSCs (Figure 6). In this model, lineage commit-
ment takes place in a nonstepwise manner. The findings that
myeloid-committed progenitors dominate the MPP fraction
and that the LMPP fraction is heterogeneous suggest that the
LMPP fraction might derive from ST-HSCs in the CD34KSL
population but not from MPPs in the CD34+KSL population in
our previous study (Morita et al., 2010). However, further studies
are required to determine differentiation pathways to progenitors
in the LMPP fraction. Furthermore, the question of whether
MPPs really exist or not needs to be revisited.
Our observations using single-cell transplantation and PDC
assays clearly showed symmetric/asymmetric self-renewal divi-
sions of HSCs and lineage commitment at the level of HSCs. In
the current study, all the data were generated by transplantation
into myeloablated hosts. That the stress of myeloablation influ-
enced self-renewal and lineage commitment processes appears
highly likely. To understand how these newly identified subsets
of HSCs and repopulating progenitors behave under phy-
siological conditions will require novel cell tracing systems or
nonmyeloablative single-cell transplantation assay systems.
Identification and characterization of differentiation pathways
in hematopoiesis are essential to identify the key molecules for
lineage commitment and to know how these regulators play a
role in pathological hematopoiesis. Our work may enable further
dissection of these processes and their mediators. In addition,
our work permits us to propose this conceptual change: Loss
of self-renewal activity in HSCs is not an essential step before
commitment to progenitors. We believe that this concept is of
critical importance not only for the field of hematopoiesis
research but also for the field of stem cell research and for devel-
opmental biology in general.EXPERIMENTAL PROCEDURES
Mice
C57BL/6-Ly5.2 (Ly5.2) and C57BL/6-Ly5.1/5.2-F1 (Ly5.1/Ly5.2-F1) mice were
purchased from Japan SLC (Shizuoka, Japan) and Sankyo-Lab Service (Tsu-
kuba, Japan), respectively. Kusabira-Orange mice (KuO mice; Hamanaka
et al., 2013) were backcrossed >7 times with C57BL/6-Ly5.1 mice. Nine- to
twelve-week-old KuO mice served as donors and 8- to 11-week-old Ly5.2
mice served as recipients. Animal experiments were approved by the Animal
Care and Use Committee, Institute of Medical Science, University of Tokyo.1124 Cell 154, 1112–1126, August 29, 2013 ª2013 Elsevier Inc.Bone Marrow Hematopoietic Cell Sorting
BM cells obtained from 9- to 12-week-old KuO mice were stained with APC-
conjugated anti-c-Kit (2B8, eBioscience, San Diego, CA) and c-Kit+ cells
were enriched using anti-APC magnetic beads (Miltenyi Biotec, Auburn, CA)
and LS columns (Miltenyi Biotec). These cells were then stained with Alexa
Fluor 700-conjugated anti-CD34 (RAM34, eBioscience), Brilliant Violet 421-
conjugated anti-CD150 (TC15-12F12.2, BioLegend, San Diego, CA), FITC-
conjugated anti-CD41 (MWReg30, eBioscience), PE-Cy7-conjugated anti-
Sca-1 (D7, eBioscience) antibodies and with a lineage-marker cocktail of
biotinylated anti-CD4 (RM4-5), -CD8 (53-6.7), -B220/CD45RA (Ly-5), -TER-
119, -Gr-1 (Ly-6G/C), and -CD127 (IL-7Ra/A7R34) antibodies (all eBio-
science), followed by staining with streptavidin-APC-Cy7 (BioLegend) to
detect biotinylated antibodies.
For MPP and LMPP sorting, BM cells isolated from KuO mice were stained
with the antibodies listed above and with PerCP-eFluor 710-conjugated anti-
Flt3 antibody (A2F10, eBioscience).
For myeloid progenitor cell sorting, BM cells isolated from KuO mice were
stained with a lineage-marker cocktail (biotinylated anti-CD4, -CD8, -B220/
CD45R, -Gr1, -TER-119, -CD127/IL7Ra, -CD3, and -CD19), Pacific Blue-con-
jugated anti-Sca-1 (D7, BioLegend), and streptavidin-APC-Cy7 after selection
of c-Kit+ cells.
Bone Marrow Transplantation
Cell were analyzed and sorted on a FACS Aria II cell sorter (special order sys-
tem, BD Biosciences, San Jose, CA). For single-cell sorting, the presence of
one cell per well was verified under an inverted microscope. Serial competitive
reconstitution assays were performed. In brief, single cells from KuO mice
mixed with 2 3 105 BM cells from Ly5.1/5.2-F1 mice were injected via tail
vein into lethally irradiated Ly5.2 mice (4.9 Gy, each of two doses, 4 hr apart).
Because no donor-derived cells were detected 1 week after transplant in mice
transplanted with single CD34KSL cells, PB cells from recipient mice were
analyzed 2, 3, 4, 8, 16, and 24 weeks after transplantation of CD34KSL cells
(in addition, some mice were also analyzed at 12 weeks, some were also
analyzed at 20 weeks, and some were also analyzed at 12 and 20 weeks).
Secondary transplantation was performed by transferring 1 3 107 BM cells
from femora and tibiae of the primary recipient mice into lethally irradiated
Ly5.2 mice. PB cells from secondary recipient mice were analyzed 4, 12, 16,
and 20 weeks after secondary transplantation.
Fifty, ten, or single Flt3CD34+KSL or Flt3+CD34+KSL cells were isolated
from KuO mouse BM cells and were transplanted into lethally irradiated
mice (Ly5.2) with 2 3 105 competitor cells (Ly5.1/Ly5.2-F1). PB analysis was
performed 7, 11, 14, 17, 20, 25, 34, 39, 53, 69, 84, 98, 115, and 145 days after
primary transplantation.
Paired Daughter Cell Assays
Single CD150+CD41CD34KSL cells from BM of KuO mice were deposited
into 96-well plates at one cell per well containing S-clone SF-O3 medium
supplemented with 1% BSA, 50 ng/ml mSCF, 50 ng/ml mTPO, penicillin,
streptomycin, L-glutamine, and 5 3 105 M 2-mercaptoethanol. When a
single mother cell underwent cell division and gave rise to two daughter cells,
the resultant two daughter cells were separated by micromanipulation. We
used a joystick micromanipulator MN-151 (Narishige, Tokyo, Japan), enabling
three-dimensional fine movement of the micropipette. We also used a micro-
injector system IM-9B on a GJ-1 magnetic stand (Narishige). Upon the first
division of an individual HSC, we aspirated one of the two daughter cells into
a glass tube using the microinjector and transferred that cell into its own
well. Each daughter cell was then transplanted into a lethally irradiated Ly5.2
mousewith 23105BMcells fromLy5.1/Ly5.2-F1mice. PB cells from the recip-
ient mice were analyzed 2, 3, 4, 8, 12, 16, and 20 weeks after transplantations;
PB of some recipient mice was also analyzed 9 days after transplantations.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and one table and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.08.007.
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